Oslo Cancer Cluster invites you to the symposium “Prostate Cancer’s Precision Promise”. Prostate Cancer is the most common cancer to effect men. The clumps of cancerous cells on the walnut-shaped prostate are slow to grow and are prone to spread to form a more aggressive deadly version. In this symposium, you will hear about the advances in the promise of precision cancer medicine that will be able to pair interdisciplinary data to provide better and more efficient treatment for cancer.

This symposium includes a networking session focusing on Horizon 2020 funding opportunities for both academia and industry in the field of cancer and personalised medicine.